All Stories

  1. Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis
  2. Development of a novel 3-month drug releasing risperidone microspheres
  3. Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin
  4. Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies